Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » neurological disorders

neurological disorders

Apr 26, 2012

IU Undertakes $150M Initiative to Expand Translational, Personalized Medicine Programs

NEW YORK (GenomeWeb News) – Indiana University has launched a new $150 million, five-year effort that will use genetics and personalized medicine, among other approaches, to develop new capabilities and translational research projects focused on cancer, neuroscience, and cardiovascular medicine,

Apr 02, 2012

Whole-Genome Sequencing of Healthy Individuals Provides Limited Risk Prediction for Common Diseases

Oct 13, 2011

NINDS Funds Salk Neuroscience Core Center

Jan 10, 2011

Janssen to Develop Assays on Biocartis MDx Platform

Janssen and J&J's Ortho-Clinical Diagnostics group have worldwide exclusive rights to develop and commercialize assays on the Biocartis platform in the fields of neurological disease and certain viral infectious diseases.

Aug 20, 2010

NIH to Fund Neurobiological Assay Research

A new NINDS and NIMH grant program will provide up to $5 million in grants to develop scalable assays for analysis of molecular and cellular events in neurons related to brain functioning.

Aug 19, 2009

NIH Awards Coriell $16M to Expand Gene Repository for Neurological Conditions

Premium

NINDS and Coriell Institute will continue to work together to expand a biorepository of clinical data and human samples that will facilitate genetic research into neurological conditions.

Apr 22, 2009

iZumi Bio's Pact with Kyoto U May Help Bolster Firm's Position as Early Leader in iPSC Tech

Premium

Although iZumi does not have a license to Kyoto iPSC patents, the collaboration builds upon other seminal iPSC IP it recently licensed from Bayer. The Kyoto deal may also help the company better define iZumi's stake in what is shaping up to be a complicated IP landscape surrounding the technology.

Apr 10, 2009

In Brief This Week: 454 Life Sciences; BioReference Laboratories; Sidmap; IDBS; GeneNews; and More

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Feb 18, 2009

NIH Launches Large Randomized Trial to Determine Utility of PGx-based Warfarin Dosing

Premium

NHLBI plans to launch next month the prospectively designed, randomized-controlled study, called Clarification of Optimal Anticoagulation through Genetics trial, which will follow 1,200 patients to see if PGx-guided dosing is clinically useful.

Pages

The Scan

Analysis for the Long Term

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

Pricey, But Available

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Pilot Cancer Testing Program for Taiwan

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

PLOS Papers on TB Resistance, Squamous Cell Carcinoma Risk, MicroRNAs in SCC

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.